Press Release - Novo Nordisk
Share our Story
Learn about our Company
ABOUT Novo Nordisk
Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.
Novo Nordisk strives to conduct its activities in a financially, environmentally and socially responsible way. The strategic commitment to corporate sustainability has brought the company onto centre stage as a leading player in todays business environment, recognised for its integrated reporting, stakeholder engagement and consistently high sustainability performance. In 2013, Novo Nordisk received the Pharmaceuticals and Biotechnology industry group top ranking on Corporate Knights list of Global 100 Most Sustainable Corporations. For more information, visit novonordisk.com/sustainability.
Copenhagen Catalogue: Sharing Good Practices in Diabetes Care
(3BL Media) September 3, 2012 - Today the Copenhagen Catalogue, a collection of concrete examples of good practices in diabetes care, is being launched. The catalogue originates from the European Diabetes Leadership Forum which took place in Copenhagen on 25-26 April 2012 emphasising that sharing information about the many existing successful practices is crucial in times of financial crisis.
“Sometimes the solution to a challenge might be just around the corner, and it is important to highlight that many good ideas don’t require massive investments”, says Lise Kingo, executive vice president, Corporate Relations, Novo Nordisk.
Looking at the 32 submitted good practices, Lise Kingo is not surprised to see that many of these are created in partnerships: “I believe public-private partnerships is a very positive option for the future. If we are to change diabetes, we all need to work together and tear down the siloes”.
Copenhagen Catalogue of Good Practices in Diabetes was introduced to facilitate knowledge sharing within the diabetes community and support the implementation of the outcomes of the European Diabetes Leadership Forum – the Copenhagen Roadmap. Whereas the Copenhagen Roadmap outlined diabetes priority areas, the Copenhagen Catalogue provides concrete examples of successful practices across Europe. The Copenhagen Catalogue publication contains good practices submitted before 30 June, marking the end of the Danish Presidency of the Council of the European Union. However, to ensure continued learning, the Catalogue will remain open for submissions.
The European Diabetes Leadership Forum was held in response to the current climate of slow economic growth and increasingly ageing populations. The Forum was arranged under the auspices of the Danish Presidency of the Council of the European Union – the Danish Ministry of Health. The Forum was proudly hosted by the Organisation of Economic Co-operation and Development (OECD) and the Danish Diabetes Association and was supported by Novo Nordisk.
For more information and to download the Copenhagen Catalogue, please visit the www.diabetesleadershipforum.eu.
Contact details:
Charlotte Zarp-Andersson
Media Relations Manager
Tel 45 3079 7603
Email: czpa@novonordisk.com
Justmeans
Facebook
Twitter
Guest
